Post surgical phone support improves outcome following knee replacement

Poor emotional health and morbid obesity are associated with less functional gain following total knee replacement (TKR) surgery. In the new study, "Can Telephone Support During Post-TKR Rehabilitation Improve Post-op Function: A Randomized Controlled Trial," presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), approximately 180 patients were categorized by gender, body mass index (BMI) and emotional health. Each patient randomly received either emotional telephone support by a trained behavioral specialist, or standard patient care. Telephone support included three phone calls before surgery, one in-person hospital visit, and eight weekly post-operative calls.

Telephone emotional support was well received by all patients. Among high-risk TKR patients, those who received telephone support reported significantly higher post-surgery physical activity and function at six months than those who received standard of care. A tailored, telephone-delivered emotional support program can be helpful in improving activity and function for patients, and especially those at risk for sub-optimal outcome.

add to favorites email to friend print save as pdf

Related Stories

Maintaining exercise when the cardiac rehab is complete

Aug 23, 2011

Researchers from The Miriam Hospital have found that patients who have completed cardiac rehabilitation and who receive telephone counseling that supports exercise are more likely to adhere to an exercise program. Results ...

HIV phone support system studied

Apr 25, 2007

A U.S. scientist is starting a study to determine the effectiveness of telephone support groups for older people with the human immunodeficiency virus.

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments